OrbiMed Private Investments V, LP Plans to Sell PMV Pharmaceuticals Common Stock

OrbiMed Private Investments V, LP has filed a Form 144 notice indicating its intention to sell 1,000,000 shares of PMV Pharmaceuticals, Inc. common stock. The shares were acquired during the company's Initial Public Offering on September 29, 2020. The planned sale is expected to occur around October 23, 2025, with an aggregate market value of approximately $1,520,000. Additionally, OrbiMed Private Investments V, LP recently sold 500,000 shares of PMV Pharmaceuticals common stock on September 10, 2025, generating gross proceeds of $900,000. OrbiMed Capital GP V LLC is the general partner of OrbiMed Private Investments V, LP, and OrbiMed Advisors LLC is the managing member of OrbiMed Capital GP V LLC.